SGLT2 Inhibitors and EMPA-KIDNEY: Revolutionizing the management of CKD
(2024) EMPA-KIDNEY - Completing the role of SGLT2i on CKD treatment with broad population patients — Location: Ha Noi, Vietnam (22.November.2024)
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Jadoul, M. (2024). SGLT2 Inhibitors and EMPA-KIDNEY: Revolutionizing the management of CKD. EMPA-KIDNEY - Completing the role of SGLT2i on CKD treatment with broad population patients, Ha Noi, Vietnam. https://hdl.handle.net/2078.5/240035